Humanin-like peptide and use thereof |
| The invention claimed is: 1. A polypeptide comprising an amino acid sequence as shown in SEQ ID NO: ... |
|
Method of treating cardiovascular diseases |
| OF PREFERRED EMBODIMENTS As examples of the diseases which the method according to the invention ... |
|
Rapid production of autologous tumor vaccines |
| In accordance with the present invention an autologous vaccine to tumor cells is produced by ... |
|
Pharmaceutical compositions comprising an adenosine receptor agonist or antagonist |
| OF THE INVENTION In accordance with the invention novel therapeutic use is provided for certain ... |
|
Engineered protein kinases which can utilize modified nucleotide triphosphate substrates |
| OF THE INVENTION Inhibition of Engineered Kinases FIG. 9 shows a schematic representation of an ... |
|
Method for the production of bacterial toxins |
| The present invention is based upon the discovery that bacterial toxin expression inhibitors ... |
|
Lactone stable formulation of 10-hydroxy 7-ethyl camptothecin and methods for uses thereof |
| OF PREFERRED EMBODIMENTS In its preferred embodiments, this invention involves preparation and ... |
|
Modified protein kinase A-specific oligonucleotides and methods of their use |
| The present invention relates to modified oligonucleotides useful for studies of gene expression ... |
|
Peptides and nucleic acid sequences related to the Epstein Barr virus |
| OF THE INVENTION The term "peptide" as used herein refers to a molecular chain of amino acids with ... |
|
|
Lactobacilli harboring aggregation gene as a vaccine delivery vehicle
| Details |
Inventors: Casas, Ivan; Jonsson, Hans; Mollstam, Bo; Roos, Stefan;
Assignee: BioGaia Biologies AB (Stockholm, SE)
Primary Examiner: Minnifield; Nita
Assistant Examiner:
Attorney, Agent or Firm: Standley & Gilcrest LLP
Live vaccines and methods for preparing the vaccines useful in protecting a host from infection by a pathogenic microorganism are provided. Vaccines are prepared from live Lactobacillus cells which have been transformed using DNA technology to express heterologous antigens of pathogenic microorganisms or other suitable biological material. Genes encoding antigenic determinants pathogenic in the mammalian gastrointestinal tract are inserted into expression cassettes and fused with genes encoding an aggregation factor and/or a mucin binding factor. The inserted genes are shown to transform L. reuteri cells. The aggregation enhancing and mucin binding genes have been isolated and sequenced. The vaccine can be ingested orally in a pharmaceutical carrier or in milk products. |
|
DETAILED DESCRIPTION OF THE INVENTION As used herein and in the claims, the term "animal" means mammals and avians, with humans being the animal of greatest interest. As used herein and in the claims, the term "L. reuteri" means any Lactobacillus microorganism that is identified as L. reuteri according to the method set forth in U. S. Pat. No. 5,352,586. As used herein and in the claims, the terms "transformed Lactobacilli or "transformed L. reuteri" mean Lactobacilli or L. reuteri into which foreign genes encoding antigenic products have been inserted. Transformed L. reuteri, or other similarly transformed bacteria particularly other Lactobacillus species, may be administered in the form of a capsule, tablet, yogurt, solution or the like. Adequate dosages to establish transformed bacteria in the normal flora of an animal to effectuate vaccination is within the skill of the artisan. All embodiments of the invention require the use of viable transformed non-virulent bacteria, preferably Lactobacilli and more preferably L. reuteri, as the organism which provides for the production of antigenic products in the animal body at sites that elicit an immune response. Vaccines according to the invention are prepared from live bacteria preferably Lactobacilli, and more preferably L. reuteri, that have been transformed so as to express antigens of microorganisms pathogenic to the host. The transformed bacteria, which serve as hosts for the expression of the antigen, can express the antigen in the cytoplasm which can then be translocated to the outer membrane of the microorganism or secreted to provide immunogens for an immunologic response by the animal host. By employing live, non-virulent bacteria as carriers for an immunogen, a strong targeted stimulus can be provided to the immune system. The antigen gene which is inserted into the host non-virulent bacteria may come from diverse sources, such as pathogenic bacteria, viruses, fungi, protozoa, or other biological material. The antigen gene may encode envelope proteins, capsid proteins, surface proteins or toxins such as exotoxins or enterotoxins
|
| Related patents |
|
|
Delivery and expression of a hybrid surface protein on the surface of gram positive bacteria
What is claimed is: 1. An isolated and purified DNA molecule encoding a hybrid protein, said hybrid protein comprising a heterologous polypeptide attached to the N-...
|
|
|
Lentiviral packaging constructs
OF THE INVENTION The practice of the present invention will employ, unless otherwise indicated, conventional techniques of cell biology, molecular biology, cell culture,...
|
|
|
Method for measuring no synthase activity
OF THE INVENTION In the context of the present invention the following definitions apply: Incubation: the introduction and leaving of a biological object, such as an ...
|
|
|
Method of enhancing proliferation or differentiation of hematopoietic stem cells using Wnt polypeptides
In one aspect, the present invention pertains to the discovery herein that Wnt polypeptides ("Wnts"), such as Wnt-5a, play a role in hematopoiesis. In another aspect, ...
|
|
|
Hydrogel compositions for controlled delivery of virus vectors and methods of use thereof
The invention relates to a composition for delivery of a virus vector to an animal cell. The composition comprises a hydrogel precursor mixture having the virus vector ...
|
|
|
Particle delivery techniques
OF THE PREFERRED EMBODIMENTS The practice of the present invention will employ, unless otherwise indicated, conventional methods of molecular biology and recombinant DNA...
|
|
|
Tissue anchor system
The invention claimed is: 1. An adjustable tissue anchor comprising: a. an anchor body having a first and second open end with an interior chamber running between said ...
|
|
|
Ribozyme mediated inactivation of the androgen receptor
The present invention describes inactivation of AR gene expression by engineering hammerhead ribozymes to cleave specific sites in AR mRNA. The present in vitro studies ...
|
|
|
Thyrotropin-releasing hormone analogues and their therapeutic applications
The present invention pertains to novel TRH analogues, compositions, and methods for the controlled administration of novel TRH analogues to mammals. The present ...
|
|
|
Probiotics in primary prevention of atopic diseases
What is claimed is: 1. A method for prevention of atopic diseases selected from the group consisting of atopic eczema, allergic rhinitis and asthma in an infant at high ...
|
|
|